1. 25LBA Impact of baseline genetic heterogeneities on progression-free survival (PFS) in patients (pts) with advanced BRAFV600-mutated melanoma treated with cobimetinib (COBI) + vemurafenib (VEM) in the phase 3 coBRIM study. (September 2015) Authors: McArthur, G.; Larkin, J.; Dréno, B.; Ascierto, P.; Liszkay, G.; Maio, M.; Mandal´, M.; Demidov, L.; Stroyakovskiy, D.; Thomas, L.; De la Cruz-Merino, L.; Atkinson, V.; Dutriaux, C.; Garbe, C.; Wongchenko, M.; Hsu, J.; Koralek, D.; Rooney, I.; Yan, Y.; Ribas, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3323 The GERMELATOX DeCOG-trial: The attitude of German melanoma patients towards toxicity during adjuvant interferon treatment - Differences between the patient's and the physician's perspective. (September 2015) Authors: Kaehler, K.C.; Augustin, M.; Blohme, C.; Forschner, A.; Gutzmer, R.; Garbe, C.; Heinzerling, L.; Kornek, T.; Livingstone, E.; Loquai, C.; Maul, L.V.; Rudolph, B.; Schadendorf, D.; Stade, B.; Terheyden, P.; Gebhardt, C.; Wagner, T.; Hauschild, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A multicentre study of naevus‐associated melanoma vs. de novo melanoma, tumour thickness and body site differences. (1st April 2021) Authors: Dessinioti, C.; Geller, A.C.; Stergiopoulou, A.; Dimou, N.; Lo, S.; Keim, U.; Gershenwald, J.E.; Haydu, L.E.; Dummer, R.; Mangana, J.; Hauschild, A.; Egberts, F.; Vieira, R.; Brinca, A.; Zalaudek, I.; Deinlein, T.; Evangelou, E.; Thompson, J.F.; Scolyer, R.A.; Peris, K. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A multicentre study of naevus‐associated melanoma vs. de novo melanoma, tumour thickness and body site differences. (1st July 2021) Authors: Dessinioti, C.; Geller, A.C.; Stergiopoulou, A.; Dimou, N.; Lo, S.; Keim, U.; Gershenwald, J.E.; Haydu, L.E.; Dummer, R.; Mangana, J.; Hauschild, A.; Egberts, F.; Vieira, R.; Brinca, A.; Zalaudek, I.; Deinlein, T.; Evangelou, E.; Thompson, J.F.; Scolyer, R.A.; Peris, K. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries. (November 2018) Authors: Kandolf Sekulovic, L.; Guo, J.; Agarwala, S.; Hauschild, A.; McArthur, G.; Cinat, G.; Wainstein, A.; Caglevic, C.; Lorigan, P.; Gogas, H.; Alvarez, M.; Duncombe, R.; Lebbe, C.; Peris, K.; Rutkowski, P.; Stratigos, A.; Forsea, A.-M.; De La Cruz Merino, L.; Kukushkina, M.; Dummer, R. Journal: European journal of cancer Issue: Volume 104(2018) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. (1st February 2018) Authors: Teramoto, Y.; Keim, U.; Gesierich, A.; Schuler, G.; Fiedler, E.; Tüting, T.; Ulrich, C.; Wollina, U.; Hassel, J.C.; Gutzmer, R.; Goerdt, S.; Zouboulis, C.; Leiter, U.; Eigentler, T.K.; Garbe, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. (20th December 2017) Authors: Teramoto, Y.; Keim, U.; Gesierich, A.; Schuler, G.; Fiedler, E.; Tüting, T.; Ulrich, C.; Wollina, U.; Hassel, J.C.; Gutzmer, R.; Goerdt, S.; Zouboulis, C.; Leiter, U.; Eigentler, T.K.; Garbe, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Adjuvant therapy for cutaneous melanoma: a systematic review and network meta‐analysis of new therapies. (6th January 2020) Authors: Longo, C.; Pampena, R.; Lallas, A.; Kyrgidis, A.; Stratigos, A.; Peris, K.; Garbe, C.; Pellacani, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 5(2020) Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Advanced cutaneous squamous cell carcinoma: real world data of patient profiles and treatment patterns. (28th October 2019) Authors: Amaral, T.; Osewold, M.; Presser, D.; Meiwes, A.; Garbe, C.; Leiter, U. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33(2019)Supplement 8 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Diagnostic accuracy of dermatofluoroscopy in cutaneous melanoma detection: results of a prospective multicentre clinical study in 476 pigmented lesions. (1st August 2018) Authors: Forschner, A.; Keim, U.; Hofmann, M.; Spänkuch, I.; Lomberg, D.; Weide, B.; Tampouri, I.; Eigentler, T.; Fink, C.; Garbe, C.; Haenssle, H.A. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗